Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2001-9-14
pubmed:abstractText
We describe the Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method set up for a sensitive and preliminary rapid screening of BRCA1 mutations. We analysed exons 11 and 16, which are known to cover slightly more than 70% of the whole coding region of the gene, subdivided into 4 amplicons and labelled with different fluorescent dUTPs. MD-CFLP was first utilised on a panel of 30 DNA samples in which the presence of single-base substitutions or small deletions/insertions had been previously identified by direct sequencing as gold standard, in order to define the optimal conditions in terms of PCR amplification and temperature of digestion. In a second step, we blindly analysed 21 DNA samples by MD-CFLP to verify its reliability. The sensitivity and specificity of MD-CFLP were both 100% in the first study, and 80% and 94%, respectively, in the blind sample assay. Our results demonstrate the capability of the MD-CFLP method to detect DNA sequence alterations in fragments of more than 1 kb. We conclude that CFLP is a powerful tool in mutational analysis, offering reliable results in a shorter time and at a lower cost than conventional methods, and its potential can be enhanced when internal fluorescent labelling and laser detection are used.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-10090881, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-7545954, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-7663517, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-7894493, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-8524414, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-8589730, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-8940459, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9042907, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9150149, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9160331, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9333265, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9353178, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9353179, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9399512, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9442913, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9563465, http://linkedlifedata.com/resource/pubmed/commentcorrection/11556835-9650932
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0007-0920
pubmed:author
pubmed:copyrightInfo
Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
845-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:11556835-BRCA1 Protein, pubmed-meshheading:11556835-Breast Neoplasms, pubmed-meshheading:11556835-DNA, Neoplasm, pubmed-meshheading:11556835-DNA Mutational Analysis, pubmed-meshheading:11556835-DNA Primers, pubmed-meshheading:11556835-Exons, pubmed-meshheading:11556835-Female, pubmed-meshheading:11556835-Fluorescent Dyes, pubmed-meshheading:11556835-Genetic Predisposition to Disease, pubmed-meshheading:11556835-Germ-Line Mutation, pubmed-meshheading:11556835-Humans, pubmed-meshheading:11556835-Nucleic Acid Conformation, pubmed-meshheading:11556835-Ovarian Neoplasms, pubmed-meshheading:11556835-Polymerase Chain Reaction, pubmed-meshheading:11556835-Polymorphism, Genetic, pubmed-meshheading:11556835-Reproducibility of Results, pubmed-meshheading:11556835-Sensitivity and Specificity
pubmed:year
2001
pubmed:articleTitle
Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method.
pubmed:affiliation
Istituto Oncologico Romagnolo, 47100 Forlì, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study